Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker Study Accompanying the AIO-TRK-0114 Study (MARBLE)

NCT02595840 is registered in ClinicalTrials.gov with Universität Duisburg-Essen as lead sponsor.

NCT NCT02595840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02595840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker Study Accompanying the AIO-TRK-0114 Study (MARBLE)
Lead sponsor
Universität Duisburg-Essen
Phase
Phase 2
Overall status
Terminated
Start date
November 25, 2015
Completion date
November 20, 2017
Enrollment
4 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

non-small-cell lung cancer with somatic egfr mutations